BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26

• 

  Business

  Trimel Pharmaceuticals, Endo International Ink NATESTO Deal For Up To $195M

  November 24, 2014

   · 

  2 min read
• Biotech Beach

  Nail Stem Cells Prove More Versatile Than Press Ons, University of Southern California Study

  November 24, 2014

   · 

  2 min read
• 

  Business

  Lundbeck Inc. CEO Ulf Wiinberg Resigns After Breach Of Company Rules

  November 24, 2014

   · 

  1 min read
• 

  Deals

  BioMarin Pharmaceutical Inc. Acquires ProSensa Holding N.V. For Up To $840M; Gaining Experimental Drisapersen

  November 24, 2014

   · 

  2 min read
• 

  Biotech Bay

  BioMarin Pharmaceutical Inc., ProSensa Holding N.V. Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome

  November 24, 2014

   · 

  2 min read
• 

  BioCapital

  Investors Expect Record Year for Biotech Venture Capital

  November 24, 2014

   · 

  2 min read
• 

  Biotech Beach

  BioPharm Executive: Top 6 Things The Life Sciences Has To Be Thankful For

  November 24, 2014

   · 

  5 min read
• Business

  LabStyle Innovations Announces Two Board Appointments

  November 24, 2014

   · 

  6 min read
• Business

  Bristol-Myers Squibb Company And Five Prime Therapeutics, Inc. Announce Exclusive Clinical Collaboration To Evaluate The Combination Of Investigational Immunotherapies Opdivo (nivolumab) And FPA008 In Six Tumor Types

  November 24, 2014

   · 

  8 min read
• Pharm Country

  Bracco Diagnostics Inc. Creates First And Only U.S. FDA-Approved Multi-Dose Compliant Contrast Medium As Breakthrough Solution For Point-Of-Care Use In The CT Suite

  November 24, 2014

   · 

  7 min read